Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02599779
Title A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

renal cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries CAN


No variant requirements are available.